A groundbreaking study published in Cardiovascular Research unveils AB-Biotics’ AB-Life probiotic strains’ profound cardiometabolic benefits in combating atherosclerotic cardiovascular diseases (ACVDs). Led by AB-Biotics, the research demonstrates how AB-Life, containing Lactiplantibacillus plantarum strains, reduces LDL particle sizes and apolipoproteins, pivotal biomarkers in atherosclerosis development. The study highlights the probiotics’ role in bile acid metabolism, lowering LDL-C and ApoB protein levels, while also improving gut microbiota composition and offering protection against dyslipidemia. This discovery underscores the potential of probiotics in enhancing cardiovascular health and prompts further investigation into their therapeutic applications.
Home » AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Nucleotide-Rich Meals and Uric Acid
September 29, 2026
Cumin Seed Extract and Its Wound-Healing Potential
September 29, 2026
Beetroot Juice and Heart Health After Menopause
September 21, 2026
Puerarin and the Gut–Liver–Brain Axis in Depression
September 21, 2026
Object Recognition Test (ORT): A Versatile Tool for Memory Research in Mice
September 14, 2026
Yeast Protein on Gut Barrier Function and Inflammation
September 14, 2026